Expanded access for genetic treatments for Sickle Cell Disease.
2025 · 4th Quarter (Oct 1 - Dec 31)
GENETIX BIOTHERAPEUTICS INC.
Filed by BALLARD PARTNERS.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Dec 29, 2025
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- BALLARD PARTNERS
- Filing UUID
- e64ad8a9-fac9-4af6-93c0-4519886af15f
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.